Innovations In Dosage Form Design Pediatrics & Patients With Dysphagia

Adare Pharma Solutions, a leading CDMO, recently acquired Orbis Biosciences, a company specializing in taste masking and controlled release solutions for oral and injectable pharmaceutical products. This acquisition has allowed Adare to expand its capabilities and offer innovative technologies to their clients.

One of the key technologies offered by Adare is Precision Particle Fabrication, which ensures uniformity in particle size and allows for precise control of release kinetics. This technology is particularly beneficial for the production of controlled release powders, providing flexibility in format and dosage. Adare has also developed a groundbreaking technology that uses vibration to create droplets, offering a significant improvement over traditional methods. This technology involves the use of anti-solvent and API+ excipients, resulting in enhanced drug delivery.

Adare offers a wide range of materials for use in drug delivery systems, including celluloses, polyesters, polyanhydrides, chitosan, waxes, lipids, and more. These materials can be used as core or shell materials in various drug delivery formats. The company has also developed Optimµm®, a competitive differentiation solution for solid oral dosage forms. This solution improves patient acceptability and provides flexibility in dose and format without compromising taste or release. 

With a focus on oral dosage form design for pediatrics and patients with dysphagia, Adare Pharma Solutions’ technologies and capabilities offer unique solutions to the pharmaceutical industry, ensuring improved drug delivery and patient experience.